Abstract:Ultrahigh dose rate FLASH radiotherapy (RT) has attracted an increased interest from researchers because of its potential of normal tissue sparing. Flash RT with an electron beam generated by a clinical linear accelerator provides a good opportunity for conducting in-vivo experiments with small animals. We developed a setup and a dosimetry procedure for murine breast irradiation with Flash RT using a clinical Linac (Elekta Synergy). Stabilized ultrahigh dose rate electron beam was generated by fine-tuning the electron gun output while gradually increasing the radio frequency (RF) power. The beam energy was slightly altered from the clinical 6 MeV beam. Dose delivery was controlled by the number of pulses of Linac operation using a single chip microcomputer. To maintain reproducibility, single - pulse mode was adopted and manually triggered until prescribed dose was met. Absolute dose measurement was performed using a calibrated Farmer chamber and Gafchromic EBT3 film. Ion charge measurement was performed by a Markus parallel plate chamber to monitor output stability. The MMTV - PyMT+/- mice of 3 - 5 weeks were irradiated in a 1 - mm thick custom-designed applicator placed at the wedge position which consisted of lead blocks, silica gel and mouse holding plate for immobilizing the mice (in prone position). A layer of 15 - mm thick silica gel was used to bring the maximum dose to the surface of the mice. The films were placed between the mice and silica gel. A total of 44 mice were irradiated in four dose levels of 6, 9, 12 and 15 Gy based on in vivo dosimetric verification. To achieve the best consistency for the dose in each pulse, the interval between two pulses was set in 20 seconds. The dose rate per pulse was 9.3 x 105 Gy/s with a beam-on time of 3.3 μs, while the average dose rate was 38.5 Gy/s (range: 33.5 ∼ 43.5 Gy/s). The average pulse number was 3.64 (range: 2 - 5 pulses). The average dose in each irradiation with 41 films measurement was 11.3 Gy (range: 5.9 - 15.4 Gy), and the average dose per pulse was 3.08 Gy (range: 2.68 - 3.48 Gy/pulse). The deviations between prescribed dose and film measurement were averaged to 2.47% (-11.93% ∼ 13.77%), and 78.0% of the data (32/41) were within ±5%. The maximum dose was within 0 - 2 mm subcutaneously to the mice, as verified by the dose depth curve measured in silica gel. A novel setup with a rigorous lab procedure was developed for murine Flash RT experiment. The effective instantaneous and average dose rate were 9.3 x 105 Gy/s, and 38.5 Gy/s, respectively. A satisfactory dose accuracy for murine breast irradiation was achieved with a custom-designed applicator.

Induced Breast Cancer Cell Apoptosis by Synchrotron-Based Irradiation with Monochromatic Microbeams

Toward Personalized Synchrotron Microbeam Radiation Therapy

Radiofrequency Heat-Enhanced Chemotherapy for Breast Cancer: Towards Interventional Molecular Image-Guided Chemotherapy.

Modulating Synchrotron Microbeam Radiation Therapy Doses for Preclinical Brain Cancer

In Vivo Microbeam Radiation Therapy at a Conventional Small Animal Irradiator

Synchrotron-based infrared microspectroscopy unveils the biomolecular response of healthy and tumour cell lines to neon minibeam radiation therapy

Technical advances in x-ray microbeam radiation therapy

A proof of principle experiment for microbeam radiation therapy at the Munich compact light source

Irradiated Engineered Tumor Cell-Derived Microparticles Remodel the Tumor Immune Microenvironment and Enhance Antitumor Immunity.

Technical and dosimetric realization of in vivo x-ray microbeam irradiations at the Munich Compact Light Source

Microbeam Radiotherapy—A Novel Therapeutic Approach to Overcome Radioresistance and Enhance Anti-Tumour Response in Melanoma

Optimization of Combined Electron and Photon Beams for Breast Cancer

Enhancement of Mitochondrial ROS Accumulation and Radiotherapeutic Efficacy Using a Gd-doped Titania Nanosensitizer

Reprogramming of the tumor microenvironment using a PCN-224@IrNCs/D-Arg nanoplatform for the synergistic PDT, NO, and radiosensitization therapy of breast cancer and improving anti-tumor immunity

Combinatorial Use of Chitosan Nanoparticles, Reversine, and Ionising Radiation on Breast Cancer Cells Associated with Mitosis Deregulation

A Set-Up for Murine Breast Irradiation with Pulsed FLASH Radiotherapy Using A Clinical Linac

TARGETED MICROBEAM IRRADIATION: STUDIES ON THE RADIOLOGICALEFFECTS AND THE ACCURACY OF PARTICLE IRRADIATION

Enhanced Antitumor Efficacy Through Microwave Ablation in Combination with Immune Checkpoints Blockade in Breast Cancer: A Pre-Clinical Study in a Murine Model.

Oxygen-evolving Photosynthetic Cyanobacteria for 2D Bismuthene Radiosensitizer-Enhanced Cancer Radiotherapy.

Potential Applications of Synchrotron Radiation to the Treatment of Cancer

A Multimodality Image Guided Precision Radiation Research Platform: Integrating X-ray, Bioluminescence, and Fluorescence Tomography with Radiation Therapy